Breast cancer drug receives 'breakthrough therapy' designation from FDA
An experimental drug being investigated for the treatment of advanced breast cancer by researchers from the Revlon/UCLA Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center this week received "breakthrough therapy" designation from the U.S. Food and Drug Administration.
Join the discussion below, or Read more at Holtville Tribune.
Since: Feb 10
Saint Petersburg, FL
#1 Apr 14, 2013
Wow. 24 1/2 months compared to 4 1/2 months -- that's finally some real progress. In 24 months you might live to see your first grandchild born, or your youngest graduate from college. Does it matter to you? In the moment, yes, but it matters to that child for the rest of his or her life.
Add your comments below
|Psychological intervention reduces fear of recu...||Jun 6||Humanspirit||1|
|Vaccine may cut HPV infections, an oral cancer ...||May '17||HPV conjob||1|
|Parker Hughes Cancer center suspending operations (Feb '08)||Apr '17||Laura||17|
|Benign tumor||Mar '17||Bharath k||1|
|Myriad Genetics Announces an Assay that Identif... (Nov '16)||Feb '17||Purplemouse2||8|
|Holzer receives donation from Fruth pharmacies||Jan '17||Steve||1|
|New team players: Palliative care specialists f...||Jan '17||Death||3|
Find what you want!
Search Oncology Forum Now
Copyright © 2017 Topix LLC